HLA-S and cancer: We evaluated immune associated gene expression levels in the TCGA Array dataset within the two risk groups, and found that human leukocyte antigens (HLAs), the key molecules mediating antigen presentation in cancer immunotherapy, were upregulated in the high-risk group (Figure 6B).